Lobbying disclosures · Lobbying report
ABT: third_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Follow ABT- Became public
- Oct 20, 2026, 12:56 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 9:48 AM EST
Why this is connected
Exact legal-name match: ABBOTT LABORATORIES (https://www.sec.gov/Archives/edgar/data/1800/).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/2ca3f414-f675-4de8-892f-bc827b18da5b/","filing_uuid":"2ca3f414-f675-4de8-892f-bc827b18da5b","filing_type":"Q3Y","filing_type_display":"3rd Quarter - Report (No Activity)","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/2ca3f414-f675-4de8-892f-bc827b18da5b/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Laurence Wilson","dt_posted":"2026-10-20T12:56:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Mass. Ave. NW #500-H","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401106196,"url":"https://lda.gov/api/v1/registrants/401106196/","house_registrant_id":null,"name":"FEDERAL HEALTH POLICY STRATEGIES","description":"Government affairs consulting","address_1":"25 Mass. Ave. NW #500-H","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RUDY MISSMAR","contact_telephone":"+1 202-448-1647","dt_updated":"2026-07-30T13:34:39.130107-04:00"},"client":{"id":211827,"url":"https://lda.gov/api/v1/clients/211827/","client_id":48,"name":"ABBOTT LABORATORIES","general_description":"Health care company","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-01"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.